These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 2654080

  • 1. [Assessment of the antiphlogistic effect of naftifin-HCl in the UV-B erythema test].
    Kecskes A, Jahn P.
    Hautarzt; 1989 Mar; 40(3):158-60. PubMed ID: 2654080
    [Abstract] [Full Text] [Related]

  • 2. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis].
    Zaun H, Luszpinski P.
    Z Hautkr; 1984 Sep 15; 59(18):1209-17. PubMed ID: 6388169
    [Abstract] [Full Text] [Related]

  • 3. [Naftifin in foot mycoses. Double-blind therapeutic comparison with clotrimazole].
    Haas PJ, Tronnier H, Weidinger G.
    Mykosen; 1985 Jan 15; 28(1):33-40. PubMed ID: 3883160
    [No Abstract] [Full Text] [Related]

  • 4. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
    Klaschka F, Gartmann H, Weidinger G.
    Z Hautkr; 1984 Sep 15; 59(18):1218-26. PubMed ID: 6388170
    [Abstract] [Full Text] [Related]

  • 5. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
    Kecskés A, Jahn P, Wendt H, Kleine-Kuhlmann R, Lange L.
    Arzneimittelforschung; 1993 Feb 15; 43(2):144-7. PubMed ID: 8457237
    [Abstract] [Full Text] [Related]

  • 6. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC, Greif C, Metzner U, Wigger-Alberti W, Elsner P.
    Skin Pharmacol Physiol; 2007 Feb 15; 20(3):133-40. PubMed ID: 17191036
    [Abstract] [Full Text] [Related]

  • 7. Topical corticosteroids in the treatment of acute sunburn: a randomized, double-blind clinical trial.
    Faurschou A, Wulf HC.
    Arch Dermatol; 2008 May 15; 144(5):620-4. PubMed ID: 18490588
    [Abstract] [Full Text] [Related]

  • 8. Topical application of solubilized Reseda luteola extract reduces ultraviolet B-induced inflammation in vivo.
    Casetti F, Jung W, Wölfle U, Reuter J, Neumann K, Gilb B, Wähling A, Wagner S, Merfort I, Schempp CM.
    J Photochem Photobiol B; 2009 Sep 04; 96(3):260-5. PubMed ID: 19656689
    [Abstract] [Full Text] [Related]

  • 9. [Double blind, randomized in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine (author's transl)].
    Hantschke D, Reichenberger M.
    Mykosen; 1980 Dec 04; 23(12):657-68. PubMed ID: 7012610
    [No Abstract] [Full Text] [Related]

  • 10. Sage extract rich in phenolic diterpenes inhibits ultraviolet-induced erythema in vivo.
    Reuter J, Jocher A, Hornstein S, Mönting JS, Schempp CM.
    Planta Med; 2007 Sep 04; 73(11):1190-1. PubMed ID: 17713873
    [Abstract] [Full Text] [Related]

  • 11. Anti-inflammatory potential of a lipolotion containing coriander oil in the ultraviolet erythema test.
    Reuter J, Huyke C, Casetti F, Theek C, Frank U, Augustin M, Schempp C.
    J Dtsch Dermatol Ges; 2008 Oct 04; 6(10):847-51. PubMed ID: 18371049
    [Abstract] [Full Text] [Related]

  • 12. Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin.
    Evans EG, James IG, Seaman RA, Richardson MD.
    Br J Dermatol; 1993 Oct 04; 129(4):437-42. PubMed ID: 8217759
    [Abstract] [Full Text] [Related]

  • 13. Investigation of the anti-inflammatory potential of Aloe vera gel (97.5%) in the ultraviolet erythema test.
    Reuter J, Jocher A, Stump J, Grossjohann B, Franke G, Schempp CM.
    Skin Pharmacol Physiol; 2008 Oct 04; 21(2):106-10. PubMed ID: 18253066
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of dermatomycosis with naftifin. Therapeutic effectiveness following once and twice daily administration].
    Meinicke K, Striegel C, Weidinger G.
    Mykosen; 1984 Dec 04; 27(12):608-14. PubMed ID: 6395017
    [No Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo cutaneous penetration and antifungal activity of naftifine.
    Stoughton RB, Sefton J, Zeleznick L.
    Cutis; 1989 Oct 04; 44(4):333-5. PubMed ID: 2805810
    [Abstract] [Full Text] [Related]

  • 16. [Naftifin in severe dermatomycosis--controlled comparison of efficacy with econazole].
    Nolting S, Weidinger G.
    Mykosen; 1985 Feb 04; 28(2):69-76. PubMed ID: 3885027
    [No Abstract] [Full Text] [Related]

  • 17. Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis.
    Smith EB, Breneman DL, Griffith RF, Hebert AA, Hickman JG, Maloney JM, Millikan LE, Sulica VI, Dromgoole SH, Sefton J.
    J Am Acad Dermatol; 1992 Jan 04; 26(1):125-7. PubMed ID: 1732321
    [No Abstract] [Full Text] [Related]

  • 18. [Naftifin--laboratory and clinical experience with a new antimycotic from the allylamine group].
    Otcenásek M, Péc J, Moravcík P.
    Cas Lek Cesk; 1993 Jun 28; 132(13):406-9. PubMed ID: 8370053
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of naftifine, a new antifungal agent.
    Georgopoulos A, Petranyi G, Mieth H, Drews J.
    Antimicrob Agents Chemother; 1981 Mar 28; 19(3):386-9. PubMed ID: 7247366
    [Abstract] [Full Text] [Related]

  • 20. Naftifine for fungal skin infections.
    Med Lett Drugs Ther; 1988 Oct 21; 30(777):98-9. PubMed ID: 3050410
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.